Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1727 of 6351
-
Could a simple ultrasound replace costly scans for liver cancer patients?
Diagnosis Recruiting nowThis phase II trial evaluates the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing treatment response in patients undergoing transarterial chemoembolization (TACE) for liver tumors. TACE is a hepatic artery embolization technique involving the injection…
Phase 2 • Sponsor: john eisenbrey • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Experimental combo targets STK11-Deficient lung cancer
Disease control PausedThe purpose of this study is to establish the safety, toxicity, and tolerability of Difluoromethylornithine (DFMO) in combination with pembrolizumab in advanced/metastatic Non-Small Cell Lung Cancer (NSCLC). Researchers also want to investigate how effective DFMO is at treating p…
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New imaging test may help doctors spot real tumor growth in kids with brain cancer
Diagnosis Recruiting nowThe purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas. Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and oth…
Early phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New lens aims to sharpen Mid-Range vision after cataract removal
Disease control CompletedThis research study is evaluating the safety and efficacy (performance) of the Bausch + Lomb enVista Beyond Hydrophobic Acrylic Extended Depth of Focus Intraocular Lens (IOL) in subjects who receive this IOL in both eyes.
Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Exercise may be the key to faster concussion recovery for soldiers
Symptom relief Recruiting nowOur primary objective is to show that early, personalized aerobic exercise treatment safely improves concussion recovery, speeds RTD, and reduces persistent symptoms in CSM. Our secondary objectives include demonstrating the clinical utility of our March-in-place test and determi…
Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New injection targets multiple myeloma in early trial
Disease control Recruiting nowThis study is a multicenter, open-label, dose-escalation/dose-expansion clinical Phase I trial designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy profile of SHR-9539 Injection in patients with multiple myeloma.
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
From CPR to overdose rescue: can a phone app turn bystanders into naloxone carriers?
Knowledge-focused OngoingThis study is a feasibility trial to assess whether, in a random sample of 180 agencies where PulsePoint is already active, revised procedures (hereinafter PulsePoint-OD) to facilitate opioid overdose and naloxone distribution (OEND) can successfully recruit first responder agenc…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
New combo therapy shows promise for tough bile duct cancer
Disease control OngoingAfter the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New diabetes drug shows promise in early trial
Disease control CompletedThe study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Particip…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Triple-Drug attack targets Hard-to-Treat leukemias
Disease control Recruiting nowTo find the recommended doses of lisaftoclax and olverembatinib that can be given in combination with decitabine to participants with advanced CML and Ph+ AML.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a smartphone app ease the burden of advanced lung cancer?
Symptom relief Recruiting nowMulti-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Experimental CAR-T therapy takes aim at Hard-to-Treat scleroderma
Disease control Stopped earlyA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects with Systemic Sclerosis
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Brain-Tracking anesthesia: a faster, smoother Wake-Up?
Symptom relief CompletedThe purpose of this research is to gather information on the effectiveness of the Sedline Brain Function Monitor, and its use in this study to determine whether monitoring the brain activity during anesthesia will improve recovery, including earlier discharge and less side effect…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New drug XB010 takes on advanced cancers in first human trial
Disease control Recruiting nowThis is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with locally advanced or metastatic solid tumors for whom alternative therapies do not …
Phase 1 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
A quick ultrasound of the thigh may reveal frailty in older ICU patients
Diagnosis CompletedThis is a single-centre prospective diagnostic study. When a patient is admitted to the inclusion centre, the clinician responsible for the patient checks the inclusion and exclusion criteria. The no objection from the patient (or their trusted support person or, failing that, a …
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New pill could help control high cholesterol Long-Term
Disease control OngoingThis is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a Sibling-Focused program shield displaced girls from anxiety and depression?
Prevention CompletedForcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to the heightened gender inequity that often accompanies forced displacement. Although the family unit has the potential to prevent m…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Anti-Aging cocktail shows promise in small pilot study
Disease control CompletedThis pilot study evaluated a multi-modal longevity protocol combining lifestyle optimisation, nutritional supplementation, and autologous cell-free conditioned media derived from peripheral blood-derived pro-regenerative cells (APRC-CM). Fourteen healthy adult participants comple…
Sponsor: BlueBird Age Reversal SA • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Heart attack patients may ditch aspirin sooner with new drug cocktail
Disease control Recruiting nowThe previous Mono Antiplatelet and Colchicine Therapy (MACT) pilot study (NCT04949516) demonstrated that it was feasible to discontinue aspirin therapy and administer low-dose colchicine on the day after percutaneous coronary intervention (PCI) in addition to potent P2Y12 inhibit…
Phase 4 • Sponsor: CHA University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple scan reveal the most dangerous form of colon cancer?
Diagnosis Recruiting nowColorectal cancer (CRC) is the 3rd most common cancer worldwide and accounts for \~14,000 new diagnoses and \~5,000 deaths in the Netherlands yearly (1.9 million and 935 thousand on a global level). Large scale transcriptional profiling of primary CRC tumors has revealed the pres…
Sponsor: UMC Utrecht • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC